NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/21/2025
Back to search
Official data from USPTO
NATIONAL BLEEDING DISORDERS FOUNDATION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NATIONAL BLEEDING DISORDERS FOUNDATION
ST13
US500000098132427Class
35, 36, 41, 44
Filing
98132427
Registration
7665088
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
01/21/2025
Trademark type
Word
Nice classes
35, 36, 41, 44
Filing date
08/14/2023
Registration date
01/21/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/21/2025
Last transaction
01/21/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
09/15/2023
First use in commerce
09/15/2023
Drawing code
4
Owner type
03
Owner location
New York, NY
Examiner
LAWRENCE, SUSAN KASTRINER
Law office
M70
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
N. F. (pessoa física)
Representatives
Dennis D. Barrett SCHANER & LUBITZ, PLLC
Technical classification
Nice Classes
Class 35Class 36Class 41Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Promoting public awareness of hemophilia and other bleeding and blood disorders by means of public advocacy; Promoting public awareness of scientific research in the field of hemophilia and other bleeding and blood disorders by means of public advocacy
Class 36
Charitable fundraising services; Charitable fundraising services by means of organizing and conducting special events; Charitable fundraising services for promoting researcheducation and other activities relating to the treatment of bleeding and blood disorders; Providing grants for research in the field of bleeding and blood disorders
Class 41
Educational servicesconducting conferencesworkshops and seminars in the field of bleeding and blood disorders; Educational servicesproviding on-line educational information in the field of bleeding and blood disorders
Class 44
Providing health information in the field of bleeding and blood disorders
Publications
History of USPTO decisions and trademark events.
26 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
01/21/2025
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
10/28/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/28/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/28/2024
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
10/28/2024
IUAA
USE AMENDMENT ACCEPTED
10/28/2024
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
10/25/2024
IUAF
USE AMENDMENT FILED
10/25/2024
EAAU
TEAS AMENDMENT OF USE RECEIVED
10/25/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/25/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/18/2024
GNRT
NON-FINAL ACTION E-MAILED
10/18/2024
CNRT
NON-FINAL ACTION WRITTEN
10/18/2024
DOCK
ASSIGNED TO EXAMINER
10/18/2024
NREV
NOTICE OF REVIVAL - E-MAILED
08/19/2024
PETG
PETITION TO REVIVE-GRANTED
08/19/2024
PROA
TEAS PETITION TO REVIVE RECEIVED
08/19/2024
MAB2
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
08/06/2024
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
08/06/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/22/2024
GNRT
NON-FINAL ACTION E-MAILED
04/22/2024
CNRT
NON-FINAL ACTION WRITTEN
04/22/2024
DOCK
ASSIGNED TO EXAMINER
04/12/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/13/2023
NWAP
NEW APPLICATION ENTERED
08/17/2023
Continuous trademark protection
Get notified about every new filing that threatens NATIONAL BLEEDING DISORDERS FOUNDATION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.